Electroencephalographic density spectral array monitoring has been developed to facilitate the interpretation of unprocessed electroencephalogram signals. The primary aim of this prospective observational study, performed in a tertiary children's hospital, was to identify the clinical applicability and validity of density spectral array monitoring in infants and children during sevoflurane anaesthesia. We included 104 children, aged < 6 years, undergoing elective surgery during sevoflurane anaesthesia. We investigated the correlation between non-steady state end-tidal sevoflurane and the expression of the four electroencephalogram frequency bands b, a, h and d, representing density spectral array. Patients were divided into three age groups (< 6 months, 6-12 months, > 12 months). There was a significant correlation between end-tidal sevoflurane and density spectral array in the age groups 6-12 months (p < 0.05) and 1-6 years (p < 0.0001). In infants < 6 months of age, the relative percentages of density spectral array did not correlate with end-tidal sevoflurane. The main finding was that different end-tidal concentrations of sevoflurane produce agedependent changes in the density spectral array power spectrum. In infants younger than 6 months-old, a and b coherence are absent, whereas h and d oscillations have already emerged. In cases where anaesthesia was too deep, this presented as burst suppression on the electroencephalogram, h disappeared, leaving the electroencephalographic activity in the d range. Future research should address this issue, aiming to clarify whether the emergence of h oscillations in infants helps to prevent sevoflurane overdosing.
Introduction
Electroencephalographic density spectral array (DSA) monitoring has been proposed to facilitate the interpretation of unprocessed electroencephalogram (EEG) signals in patients undergoing general anaesthesia [1] .
Encephalographic DSA is a three-dimensional method to display EEG signals consisting of the EEG frequency (y-axis), the power of the EEG signal (originally the z-axis, but colourcoded to be integrated into a two-dimensional plot) and the development of the EEG power spectrum over time (x-axis).
The power spectrum is encoded in different colours; blue implies minimal power and red implies high or maximal power [1, 2] . Compared with processed EEG monitoring, DSA provides real-time EEG information [3] . One of the major advantages of real-time DSA EEG monitoring is the lack of any delay in detecting even subtle changes in the depth of hypnosis. However, DSA has not yet been widely implemented in the daily practice of paediatric anaesthesia.
We decided to investigate the additional value of DSA in children undergoing sevoflurane anaesthesia. The primary outcome parameter of this prospective observational study in children < 6 years of age was to determine the correlation between DSA and various non-steady-state sevoflurane concentrations.
Methods
Following local research ethics committee approval, informed consent was obtained from the parents of all the children. We included children from birth to 6 years of age, scheduled to undergo elective surgery in the Based on previously performed studies [4, 5] , patients were divided into three different age groups (< 6 months; 6-12 months; and 1-6 years) for analysis.
In order to investigate variations in total power between different age groups, we performed a one-way ANOVA with a Games-Howell post-hoc test. Spearman correlation was performed to analyse the correlation between ET sevo and the relative EEG power percentages. The relationship between DSA relative power and ET sevo was displayed using a heatmap, a graphical tool representing grouped data. 
Results
We recorded data in 108 children. Data from four patients had to be excluded; one patient was not included due to the use of premedication (group 3) and three due to technical issues with data collection (two who were < 6 months old and one who was between 1-6 years of age). This resulted in 104 datasets being available for analysis. Baseline characteristics of patients included in the study are shown in Table 1 .
There was a significant difference in total power between the three different age groups (Table 2 ). There was a significant correlation between ET sevo and relative EEG power in b, a, h and d in children aged 6-12 months The Narcotrend index calculation failed in 13% of patients age < 6 months compared with 3% age 6-12 months. In 39% of patients age < 6 months Narcotrend index monitoring partially failed, compared with 7% in age 6-12 months and 6% age 1-6 years.
In three patients, propofol was administered during maintenance of anaesthesia because the surgeon reported patient movement. In two of these patients (age < 6 months) no difference in DSA colour spectrum was 
Discussion
The main finding of this clinical observational study is that different end-tidal concentrations of sevoflurane produce changes in DSA power spectrum and appear to be age dependent.
In children > 6 months, heatmaps show a profound dose-dependent sevoflurane effect on EEG power. This effect is less obvious in infants < 6 months. With increasing age, a significant increase in EEG total power was identified.
This finding is in accordance with a previously performed study by Akeju et al. [4] . The a coherence is defined as a prominent EEG feature associated with sevofluraneinduced general anaesthesia [1, 6] . In our study, in patients approximately 4 months of age [7] .
Processed EEG devices such as the bispectral index monitor and the Narcotrend index monitor are more often used in paediatric anaesthesia practice than DSA. The studies designed to validate these monitors in children were mostly performed in those aged > 5 months and were mainly focused on the ability of an index value to distinguish between the awake and the unconsciousness state [8, 9] .
Dennhardt et al. [10] recently investigated the effect of age on Narcotrend index monitoring during sevoflurane anaesthesia. They reported limited feasibility of the Narcotrend index monitor in infants < 4 months of age due to the lower likelihood (29.6%) of showing a Narcotrend index. In our study, the feasibility of the Narcotrend index to generate a value was also reduced in A limitation of this study is that we only focused on the effect of ET sevo on DSA and did not use a clinical scale or scoring system to monitor anaesthetic depth. As a consequence, we cannot use this study as validation to investigate the ability of DSA to differentiate between different levels of consciousness in young children.
In conclusion, this observational study provides additional evidence of the applicability of DSA as a measure of anaesthetic depth in young children undergoing sevoflurane anaesthesia. We believe there is an additional value to DSA in hypnotic depth monitoring in children aged 6 months to 6 years due to a significant correlation between DSA and ET sevo . In infants < 6 months, DSA may be a useful tool in preventing sevoflurane overdosing due to the emergence of h expression. Further research using DSA should specifically address the issue of sevoflurane overdosing in infants aged 0-6 months.
